Why are clinical development success rates falling?

Published on May 16, 2024

Likelihood of approval for new Phase I drugs is now just 6.7% Phase transition data from Citeline for the 10-year period between 2014ؘ and 2023 show that the average likelihood of approval (LOA) for a new Phase I drug is now just 6.7%. This has steadily fallen in each analysis to an all-time low. The […]

Continue reading on website
Other news

BioPharma Reporter: Abzena at BIO 2024 Showcasing Innovation in Cell Line Development Technology

May 15, 2024
BioPharma Reporter’s latest issue shares what Abzena, an end-to-end CDMO for biologics and bioconjugates, will be presenting its latest AbZelect and AbZelectPRO cell line development (CLD) platforms and more at BIO 2024.BPR: What new products or innovations is Abzena showcasing at BIO 2024 this year?Abzena has recently launched our AbZelect and AbZelectPRO cell line development (CLD) platforms, to

A Look into Being a Utilities Management Specialist: Colleague Spotlight on Michael Boylan

May 16, 2024
Michael went to Orleans Tech to pursue a career as an electrician which culminated in a 29-year role as a certificated electrician with HVAC specializations. Michaels’ successful career journey led to his current high-impact role at Abzena, where he oversees multiple duties related to pharmaceutical maintenance.  Seeking a challenge, Michael understands that Abzena’s innovative approach and leadin